Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapyCELL COMMUNICATION AND SIGNALINGIF8.92024-09-093OAAI
Editorial: Cellular and molecular mechanisms in social and repetitive behaviours: a focus on cortico-striatal circuitryFRONTIERS IN CELLULAR NEUROSCIENCEIF42024-08-080OAAI
Dissecting the autism-associated 16p11.2 locus identifies multiple drivers in neuroanatomical phenotypes and unveils a male-specific role for the major vault proteinGENOME BIOLOGYIF9.42023-11-158OAAI
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2EMBO MOLECULAR MEDICINEIF8.32023-10-043OAAI
Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disordersNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92022-11-0135OAAI
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesiaBRITISH JOURNAL OF PHARMACOLOGYIF7.72022-01-122OAAI
A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric DisordersPHARMACEUTICALSIF4.82021-10-283OAAI
Dopamine D1 and Glutamate Receptors Co-operate With Brain-Derived Neurotrophic Factor (BDNF) and TrkB to Modulate ERK Signaling in Adult Striatal SlicesFRONTIERS IN CELLULAR NEUROSCIENCEIF42020-11-1612OAAI
Enhancing cognition through pharmacological and environmental interventions: Examples from preclinical models of neurodevelopmental disordersNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92020-03-0113PREAI
Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatinSCIENTIFIC REPORTSIF3.92018-10-1811OAAI
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsBRITISH JOURNAL OF PHARMACOLOGYIF7.72018-01-3115OAAI
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsyNEUROBIOLOGY OF DISEASEIF5.62017-03-01150OAAI
Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathiesBIOLOGICAL PSYCHIATRYIF92017-02-0132PREAI
Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitorsELIFEIF02016-08-2439OA
Synaptic GluN2B/CaMKII-α Signaling Induces Synapto-Nuclear Transport of ERK and JacobFRONTIERS IN MOLECULAR NEUROSCIENCEIF3.82016-08-1031OAAI
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylationPSYCHOPHARMACOLOGYIF3.32016-05-3111PREAI
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor ControlCELL REPORTSIF6.92015-11-0149OAAI
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's diseasePROGRESS IN NEUROBIOLOGYIF6.12015-09-01395OAAI
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesiaANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGYIF3.92015-04-2418OAAI
Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome familyEUROPEAN JOURNAL OF HUMAN GENETICSIF4.62015-02-2512OAAI